Prevention of meningococcal serogroup B infections in children: A protein-based vaccine induces immunologic memory

Journal of Infectious Diseases

Volumn 184, Issue 1, 2001, Pages 98-102

  De Kleijn, Ester D ^a   De Groot, Ronald ^a   Lafeber, Arianne B ^b   Labadie, Jerry ^b   Van Limpt, Cees J P ^b   Visser, John ^a   Berbers, Guy A M ^b   Van Alphen, Loek ^b   Rümke, Hans C ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL OUTER MEMBRANE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CROSS REACTION; DRUG INDUCED DISEASE; ERYTHEMA; FEVER; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INJECTION SITE; MAJOR CLINICAL STUDY; MENINGITIS; MENINGOCOCCOSIS; PAIN; PRIORITY JOURNAL; REVACCINATION; SEROTYPE; VACCINATION;

ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS;

EID: 0035400040     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320993     Document Type: Article

References (16)

1. Human antibody to a group B serotype 2a meningococcal vaccine determined by immunoblotting
2. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: Comparison with efficacy
3. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent outer membrane vesicle vaccine
4. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: A randomized controlled trial in Chile
5. Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis: Synthetic peptides define the epitopes responsible for serosubtype specificity
6. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: A brief survey
7. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
8. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines
9. Protective efficacy of a serogroup B meningococcal vaccine in São Paulo, Brazil
10. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile
11. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
12. Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children 2-3 and 7-8 years of age
13. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
14. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
15. T-cell responses to outer membrane proteins of Neisseria meningitidis: Comparative study of the Opa, Opc, and PorA proteins
16. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins